Anti-ABCC9/ ABC37/ ATFB12 monoclonal antibody

Anti-ABCC9/ ABC37/ ATFB12 antibody for FACS & in-vivo assay

Target products collectionGo to ABCC9/ABCC9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T02777-Ab-1/ GM-Tg-hg-T02777-Ab-2Anti-Human ABCC9 monoclonal antibodyHuman
GM-Tg-rg-T02777-Ab-1/ GM-Tg-rg-T02777-Ab-2Anti-Rat ABCC9 monoclonal antibodyRat
GM-Tg-mg-T02777-Ab-1/ GM-Tg-mg-T02777-Ab-2Anti-Mouse ABCC9 monoclonal antibodyMouse
GM-Tg-cynog-T02777-Ab-1/ GM-Tg-cynog-T02777-Ab-2Anti-Cynomolgus/ Rhesus macaque ABCC9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T02777-Ab-1/ GM-Tg-felg-T02777-Ab-2Anti-Feline ABCC9 monoclonal antibodyFeline
GM-Tg-cang-T02777-Ab-1/ GM-Tg-cang-T02777-Ab-2Anti-Canine ABCC9 monoclonal antibodyCanine
GM-Tg-bovg-T02777-Ab-1/ GM-Tg-bovg-T02777-Ab-2Anti-Bovine ABCC9 monoclonal antibodyBovine
GM-Tg-equg-T02777-Ab-1/ GM-Tg-equg-T02777-Ab-2Anti-Equine ABCC9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-T02777-Ab-1/ GM-Tg-hg-T02777-Ab-2; GM-Tg-rg-T02777-Ab-1/ GM-Tg-rg-T02777-Ab-2;
GM-Tg-mg-T02777-Ab-1/ GM-Tg-mg-T02777-Ab-2; GM-Tg-cynog-T02777-Ab-1/ GM-Tg-cynog-T02777-Ab-2;
GM-Tg-felg-T02777-Ab-1/ GM-Tg-felg-T02777-Ab-2; GM-Tg-cang-T02777-Ab-1/ GM-Tg-cang-T02777-Ab-2;
GM-Tg-bovg-T02777-Ab-1/ GM-Tg-bovg-T02777-Ab-2; GM-Tg-equg-T02777-Ab-1/ GM-Tg-equg-T02777-Ab-2
Products NameAnti-ABCC9 monoclonal antibody
Target NameABCC9
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
Products descriptionPre-made anti-ABCC9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ABCC9/ ABC37/ ATFB12 VLP (virus-like particle) (Products Developing)

    Target information

    Target IDGM-T02777
    Target NameABCC9
    Gene ID10060,20928,25560,654489,486638,101096657,100336551,111767477
    Gene Symbol and SynonymsABC37,ABCC9,ATFB12,CANTU,CMD1O,IDMYS,SUR2,SUR2A,SUR2B
    Uniprot AccessionO60706,Q63563
    Uniprot Entry NameABCC9_HUMAN,ABCC9_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    Gene EnsemblENSG00000069431
    Target ClassificationN/A

    The target: ABCC9, gene name: ABCC9, also named as ABC37, ATFB12, CANTU, CMD1O, SUR2. The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is thought to form ATP-sensitive potassium channels in cardiac, skeletal, and vascular and non-vascular smooth muscle. Protein structure suggests a role as the drug-binding channel-modulating subunit of the extra-pancreatic ATP-sensitive potassium channels. Mutations in this gene are associated with cardiomyopathy dilated type 1O. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2011].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.